The feasibility of HIV vaccine efficacy trials among Russian injection drug users

Christopher Beyrer, Stefan Baral, Alla Shaboltas, Elena Dukhovlinova, Alexey Masharsky, Sergey Verevochkin, Carl A Latkin, Robert Heimer, Irving Hoffman, Andrei Kozlov

Research output: Contribution to journalArticle

Abstract

IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.

Original languageEnglish (US)
Pages (from-to)7014-7016
Number of pages3
JournalVaccine
Volume25
Issue number41
DOIs
StatePublished - Oct 10 2007

Fingerprint

drug injection
AIDS Vaccines
Drug Users
primary contact
HIV
vaccines
incidence
Injections
Russia
drug therapy
Incidence
genetic variation
Vaccines
Pharmaceutical Preparations
Therapeutics

Keywords

  • HIV
  • Injection drug use
  • Molecular epidemiology
  • St. Petersburg
  • Vaccines

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Beyrer, C., Baral, S., Shaboltas, A., Dukhovlinova, E., Masharsky, A., Verevochkin, S., ... Kozlov, A. (2007). The feasibility of HIV vaccine efficacy trials among Russian injection drug users. Vaccine, 25(41), 7014-7016. https://doi.org/10.1016/j.vaccine.2007.07.028

The feasibility of HIV vaccine efficacy trials among Russian injection drug users. / Beyrer, Christopher; Baral, Stefan; Shaboltas, Alla; Dukhovlinova, Elena; Masharsky, Alexey; Verevochkin, Sergey; Latkin, Carl A; Heimer, Robert; Hoffman, Irving; Kozlov, Andrei.

In: Vaccine, Vol. 25, No. 41, 10.10.2007, p. 7014-7016.

Research output: Contribution to journalArticle

Beyrer, C, Baral, S, Shaboltas, A, Dukhovlinova, E, Masharsky, A, Verevochkin, S, Latkin, CA, Heimer, R, Hoffman, I & Kozlov, A 2007, 'The feasibility of HIV vaccine efficacy trials among Russian injection drug users', Vaccine, vol. 25, no. 41, pp. 7014-7016. https://doi.org/10.1016/j.vaccine.2007.07.028
Beyrer, Christopher ; Baral, Stefan ; Shaboltas, Alla ; Dukhovlinova, Elena ; Masharsky, Alexey ; Verevochkin, Sergey ; Latkin, Carl A ; Heimer, Robert ; Hoffman, Irving ; Kozlov, Andrei. / The feasibility of HIV vaccine efficacy trials among Russian injection drug users. In: Vaccine. 2007 ; Vol. 25, No. 41. pp. 7014-7016.
@article{4fbf8b5cfe604c1bb8faaf7c246956df,
title = "The feasibility of HIV vaccine efficacy trials among Russian injection drug users",
abstract = "IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.",
keywords = "HIV, Injection drug use, Molecular epidemiology, St. Petersburg, Vaccines",
author = "Christopher Beyrer and Stefan Baral and Alla Shaboltas and Elena Dukhovlinova and Alexey Masharsky and Sergey Verevochkin and Latkin, {Carl A} and Robert Heimer and Irving Hoffman and Andrei Kozlov",
year = "2007",
month = "10",
day = "10",
doi = "10.1016/j.vaccine.2007.07.028",
language = "English (US)",
volume = "25",
pages = "7014--7016",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "41",

}

TY - JOUR

T1 - The feasibility of HIV vaccine efficacy trials among Russian injection drug users

AU - Beyrer, Christopher

AU - Baral, Stefan

AU - Shaboltas, Alla

AU - Dukhovlinova, Elena

AU - Masharsky, Alexey

AU - Verevochkin, Sergey

AU - Latkin, Carl A

AU - Heimer, Robert

AU - Hoffman, Irving

AU - Kozlov, Andrei

PY - 2007/10/10

Y1 - 2007/10/10

N2 - IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.

AB - IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.

KW - HIV

KW - Injection drug use

KW - Molecular epidemiology

KW - St. Petersburg

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=34648831918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648831918&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.07.028

DO - 10.1016/j.vaccine.2007.07.028

M3 - Article

VL - 25

SP - 7014

EP - 7016

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 41

ER -